Chipotle Mexican Grill Executive Says Transaction Trends Improved Through Q4, Turned Positive Entering 2023

-Reuters

-Reuters

Total
0
Shares
Related Posts
Read More

Why Arrowhead Pharmaceuticals Shares Are Moving

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) shares are trading higher by 5.4% to $32.68, gaining after initially falling, after the company priced an underwritten registered offering of about 15.79 million shares of its common stock at $28.50 per share, expecting to close around

ARWR